Boundless Bio (BOLD) Change in Acquisitions & Divestments (2023 - 2026)

Boundless Bio (BOLD) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $44.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 21.07% year-over-year to $44.0 million; the TTM figure through Mar 2026 stood at $201.5 million (changed 0.05% YoY), while the FY2025 annual figure was $213.2 million, up 15.33% from the prior year.
• Change in Acquisitions & Divestments fell to $44.0 million in Q1 2026 per BOLD's latest filing, from $52.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $59.0 million in Q3 2024 and bottomed at $19.0 million in Q2 2023.
• Historically, Change in Acquisitions & Divestments has averaged $43.4 million across 4 years, with a median of $44.0 million in 2026.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments soared 112.58% — and 2026, when it slipped 21.07%.
• Boundless Bio's Change in Acquisitions & Divestments stood at $43.5 million in 2023, then increased by 14.31% to $49.7 million in 2024, then gained by 5.58% to $52.5 million in 2025, then retreated by 16.19% to $44.0 million in 2026.
• Business Quant data shows BOLD's Change in Acquisitions & Divestments at $44.0 million in Q1 2026, $52.5 million in Q4 2025, and $50.0 million in Q3 2025.